Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Teens develop septic shock due to COVID-19

Since the emergence of the novel coronavirus disease (COVID-19), most people who develop severe illness are older adults, those with underlying medical conditions, and those who are immunocompromised. Though children are mostly spared, some adolescents developed septic shock due to COVID-19, a new study has found.

24 May 2020

Heparin may stop SARS-CoV-2 infecting host cells

Researchers at the University of Sheffield have developed a new assay that can be used to assess the attachment of viruses to host cells and to test potential inhibitors of viral infection.

24 May 2020

New biomarkers to consider for SARS-CoV-2 vaccine

Researchers at the University of Melbourne have made new discoveries about how the immune system responds to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that could be important to consider in vaccine research.

24 May 2020

Study shows cats can harbor SARS-CoV-2 without any symptoms

A recent paper from Spanish researchers at the Hospital Universitario San Pedro-CIBIR, available on the medRxiv* preprint server, suggests that cats may act as asymptomatic dispersers of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), even though viral transmission from animals to humans still seems highly unlikely.

24 May 2020

Smokers at increased risk of severe COVID-19 according to a large population study

A new UK study available on the preprint server medRxiv screened 2.4 million users of a symptom reporting application during the coronavirus disease (COVID-19) pandemic, revealing that smokers are at higher risk of increased symptom burden and more prone to hospitalization.

24 May 2020

Treatment with chloroquine or hydroxychloroquine offers no benefit for COVID-19 patients

A large observational study suggests that treatment with the antimalarial drug chloroquine or its analog hydroxychloroquine (taken with or without the antibiotics azithromycin or clarithromycin) offers no benefit for patients with COVID-19.

22 May 2020

First COVID-19 vaccine found to be safe, able to generate rapid immune response in phase 1 clinical trial

The first COVID-19 vaccine to reach phase 1 clinical trial has been found to be safe, well-tolerated, and able to generate an immune response against SARS-CoV-2 in humans, according to new research published in The Lancet.

22 May 2020

Study finds evidence of injury in placentas from COVID-19-positive pregnant women

The placentas from 16 women who tested positive for COVID-19 while pregnant showed evidence of injury, according to pathological exams completed directly following birth, reports a new Northwestern Medicine study.

22 May 2020

Children's National receives FCC funding to establish regional pediatric telehealth consortium

Children's National Hospital is establishing a regional pediatric telehealth consortium in response to coronavirus with $928,000 in funding awarded by the Federal Communications Commission's Wireline Competition Bureau.

22 May 2020

Coronavirus tests the value of artificial intelligence in medicine

Dr. Albert Hsiao and his colleagues at the University of California-San Diego health system had been working for 18 months on an artificial intelligence program designed to help doctors identify pneumonia on a chest X-ray. When the coronavirus hit the United States, they decided to see what it could do.

22 May 2020

The 30-somethings who fled big cities to shelter with mom and dad

It took three weeks, but Lawrence and Arlene Maze finally persuaded their younger son, Gregory, of Los Angeles, to get on a flight home to Austin.

22 May 2020

Survey highlights the impact of COVID-19 on consumers’ ability to purchase day-to-day food

People have shared their experiences of supermarket shopping following the recent phase of panic-buying and subsequent restrictions, with many reporting problems buying basic goods.

22 May 2020

Portable analyzer rapidly detects anti-virus antibody in blood serum

Researchers have succeeded in detecting anti-avian influenza virus antibody in blood serum within 20 minutes, using a portable analyzer they have developed to conduct rapid on-site bio tests. If a suitable reagent is developed, this technology could be used to detect antibodies against SARS-CoV-2, the causative virus of COVID-19.

22 May 2020

Different immune responses can occur in Covid-19, shows study

The human immune system is reactive to more than just the viral protein on which researchers have focused to date. This is relevant for tests and potential vaccines.

22 May 2020

IberoGEN develops kit to detect coronavirus on surfaces susceptible to contamination

Company IberoGEN at the Miguel Hernández University of Elche (UMH) has developed a test for the early detection of coronavirus on surfaces susceptible to contamination from everyday use, such as handles, railings, switches, telephones, and keyboards, which is intended for comprehensive service companies as well as specialised entities.

22 May 2020

UAE develops laser-based technology for faster, mass-scale coronavirus screening

QuantLase Imaging Lab, the medical-research arm of the Abu Dhabi Stock Exchange-listed International Holdings Company (IHC), announced that it has developed novel equipment which enables for much faster mass screenings, with test results available in seconds and allowing testing on a wider scale.

22 May 2020